Artificial Intelligence Collides with FDA Bureaucracy: News Article

The collision between rapid AI innovation and rigid FDA oversight highlights the growing tension in regulating diagnostic tools that evolve faster than current policy frameworks. This regulatory friction risks delaying life-saving medical advancements while regulators struggle to ensure safety without stifling technological progress.